Skip to content

Author

L. Østergaard

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Non-Traditional Antibacterial Agents Relevant to the WHO 2024 Priority Pathogens: A Structured Update of the Clinical Pipeline

The pipeline is dominated by bacteriophages and markedly skewed toward carbapenem-resistant Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), with few or no candidates targeting carbapenem-resistant Acinetobacter baumannii (CRAB), Shigella or Salmonella.

M. K. Hansen, L. Østergaard · 0 citations
Review Open access Aug 2026

The Epidemiological and Economic Burden of Vaccine-Preventable Respiratory Diseases Among Adults Aged 65 Years and Older in the Nordic Countries

Despite national vaccination efforts, VPRDs remain a major health and economic burden in the Nordic countries and strengthening immunization programs through improved vaccine uptake, broader coverage, and use of advanced vaccines may contribute to further reducing this burden.

Nicoline Weinreich Reinstrup, Renée Hangaard Gidsel, T. Heikkinen et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.